TY  - JOUR
AU  - Meixner, Eva
AU  - Hoeltgen, Line
AU  - Dinges, Lisa A
AU  - Harrabi, Semi
AU  - Seidensaal, Katharina
AU  - Weykamp, Fabian
AU  - Hoegen-Sassmanshausen, Philipp
AU  - Vinsensia, Maria
AU  - König, Laila
AU  - Deng, Maximilian
AU  - Debus, Jürgen
AU  - Hörner-Rieber, Juliane
TI  - Efficacy of palliative hemostatic radiotherapy for tumor bleeding and pain relief in locally advanced pelvic gynecological malignancies.
JO  - Strahlentherapie und Onkologie
VL  - 201
SN  - 0179-7158
CY  - Heidelberg
PB  - Springer Medizin
M1  - DKFZ-2024-02363
SP  - 528–536
PY  - 2025
N1  - #LA:E050# / Volume 201, pages 528–536, (2025) 
AB  - The appearance of symptomatic tumor-related vaginal bleeding and pain in advanced incurable cancer patients with pelvic gynecological malignancies remains a therapeutic challenge in oncological treatment. The aim of our analysis was to evaluate the efficacy and safety of palliative hemostatic radiotherapy.We retrospectively identified patients who had received palliative hemostatic radiotherapy (RT) at our institution between 2011 and 2023 and evaluated acute toxicity, local control, cessation of bleeding, and pain relief.In total, 40 patients with a median planning target volume of 804 cm3 were treated with a median total dose of 39 Gy in 13 fractions, resulting in 6‑month and 1‑year local control rates of 66.9 and 60.8
KW  - Anticoagulation (Other)
KW  - Cancer vaginal bleeding (Other)
KW  - Hypofractionated radiation therapy (Other)
KW  - Re-irradiation (Other)
KW  - Transfusion (Other)
LB  - PUB:(DE-HGF)16
C6  - pmid:39531126
DO  - DOI:10.1007/s00066-024-02319-2
UR  - https://inrepo02.dkfz.de/record/294593
ER  -